MedPath

RiboCor, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Phase 2
Withdrawn
Conditions
Congestive Heart Failure
Interventions
Other: Placebo
First Posted Date
2013-05-21
Last Posted Date
2016-07-14
Lead Sponsor
RiboCor, Inc.
Registration Number
NCT01858480
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Southeast Regional Research Group, Columbus, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Medical Consultants PC, Muncie, Indiana, United States

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal General Hospital / MUHC, Montreal, Quebec, Canada

and more 21 locations

D-Ribose for Fatigue in Subjects With Fibromyalgia

Phase 2
Completed
Conditions
Fibromyalgia
Interventions
Dietary Supplement: Placebo Powder
First Posted Date
2011-03-15
Last Posted Date
2013-09-18
Lead Sponsor
RiboCor, Inc.
Target Recruit Count
110
Registration Number
NCT01315210
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky, Lexington, Kentucky, United States

๐Ÿ‡บ๐Ÿ‡ธ

Superior Research, LLC, Sacramento, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Peters Medical Research, High Point, North Carolina, United States

and more 6 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath